With new funding, Atomic AI envisions RNA as the next frontier in drug discovery

Amidst the abundance of news about Artificial Intelligence (AI) and its applications, a rather interesting development has taken place in the latest advancements in drug discovery research. Recent funding to Atomic AI, a San Franciscan based company, has opened up a new frontier in the search for treatments and cures to diseases. By harnessing the… Continue reading With new funding, Atomic AI envisions RNA as the next frontier in drug discovery

6 investors discuss why AI is more than just a buzzword in biotech

In recent years, artificial intelligence (AI) has been one of the most talked-about technologies in the world, particularly in the medical and biotechnology space. As more companies move toward integrating AI into their workflows, the industry buzz has shifted from AI being a ‘buzzword’ to an essential tool in achieving rapid advancements in medical and… Continue reading 6 investors discuss why AI is more than just a buzzword in biotech

Exit mobile version